Neurophysiological evidence of cognitive impairment in patients without hepatic encephalopathy after transjugular intrahepatic portosystemic shunts

American Journal of Gastroenterology

Volumn 97, Issue 1, 2002, Pages 162-166

  Kramer, Ludwig ^a,b   Bauer, Edith ^a   Gendo, Alexandra ^a   Funk, Georg ^a   Madl, Christian ^a   Pidlich, Johann ^a   Gangl, Alfred ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLEEDING; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE EXACERBATION; EVENT RELATED POTENTIAL; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; LATENT PERIOD; LIVER CIRRHOSIS; MALE; MEDIAN NERVE; NERVE POTENTIAL; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; PSYCHOMETRY;

ADULT; AGE DISTRIBUTION; AGED; CASE-CONTROL STUDIES; CHRONIC DISEASE; COGNITION DISORDERS; COHORT STUDIES; EVOKED POTENTIALS, SOMATOSENSORY; FEMALE; HEPATIC ENCEPHALOPATHY; HUMANS; INCIDENCE; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; PROBABILITY; RISK FACTORS; SEX DISTRIBUTION; STATISTICS, NONPARAMETRIC;

EID: 0036143626     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(01)04003-5     Document Type: Article

References (35)

1. The first decade of the transjugular intrahepatic portosystemic shunt (TIPS): State of the art
2. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites
3. TIPS for prevention of recurrent bleeding in patients with cirrhosis: Meta-analysis of randomized clinical trials
4. Predictors of clinical response to transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients with refractory ascites
5. Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: Clinical, laboratory, psychometric, and electroencephalographic investigations
6. The P300 wave of the human event-related potential
7. Previous episodes of hypoglycemic coma are not associated with permanent cognitive brain dysfunction in IDDM on intensive insulin treatment
8. Modest decrement in plasma glucose concentration causes early impairment in cognitive function and later activation of glucose counterregulation in the absence of hypoglycemic symptoms in normal man
9. Asymptomatic sequelae to acute sarin poisoning in the central and autonomic nervous system 6 months after the Tokyo subway attack
10. Subclinical hepatic encephalopathy: The diagnostic value of evoked potentials
11. Improvement of hepatic encephalopathy treated with flumazenil
12. Somatosensory evoked potentials in subclinical portosystemic encephalopathy: A comparison with psychometric tests
13. Somatosensory evoked potentials in hepatic encephalopathy
14. Urgent transjugular intrahepatic portosystemic shunt for control of acute variceal bleeding
15. Validity of the trail making test as an indicator of organic brain damage
16. "Mini-mental state": A practical method for grading the cognitive state of patients for the clinician
17. Hepatic encephalopathy in the age of TIPS
18. Magnetic resonance imaging and proton spectroscopic alterations correlate with parkinsonian signs in patients with cirrhosis
19. Effects of visual impairment on neuropsychological test performance
20. Rapid recovery from cognitive deficits in abstinent alcoholics: A controlled testretest study
21. The number connection tests A and B: Interindividual variability and use for the assessment of early hepatic encephalopathy
22. Subclinical hepatic encephalopathy - Does it exist?
23. Visual eventrelated potentials in cirrhotic patients without overt encephalopathy
24. Beneficial effect of renal transplantation on cognitive brain function
25. MRI findings in chronic hepatic encephalopathy depend on portosystemic shunt: Results of a controlled prospective clinical investigation
26. A prospective evaluation of changes in neuropsychological and liver function tests following transjugular portosystemic stent-shunt
27. Neuroactive amino acids in hepatic encephalopathy
28. Manganese and chronic hepatic encephalopathy
29. Randomised trial of transjugular-intrahepatic portosystemic shunt versus endoscopy for prevention of variceal rebleeding
30. Brain edema and portal-systemic encephalopathy
31. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunts: Incidence and risk factors
32. Ammonia: A key factor in the pathogenesis of hepatic encephalopathy
33. Cognitive impairment in alcoholic and nonalcoholic cirrhosis patients